Do you want to read an article? Please log in or register.
Janus Kinase Inhibitors for Inflammatory Bowel Disease: Concise Questions and Answers on Their Use in Clinical Practice
Inflammatory Bowel Disease
Related content
RECOMMENDED
Inflammatory Bowel Disease
Janus kinase (JAK) inhibitor-induced acne in inflammatory bowel disease - an international, multicenter, retrospective cohort study
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Clin Gastroenterol Hepatol
Honap S, Temido MJ, Shakweh E, Badrulhisham F, Shields N, Mehta S, McBride J, Uzzan M, Lukáš M, Fumery M, Nogami A, Kobayashi T, Nancey S, Neves JC, Mendes JM, Wegener BA, Bergereau E, Fernandes R, Kuriakose Kuzhiyanjal AJ, Vieujean S, Spencer A, Baillie S, Estevinho MM, Simão I, O'Neill C, Gututui M, Thompson E, Jama A, Chai N, Pavlidis P, D'Amico F, Limdi J, Magro F, Sebastian S, Digby-Bell J, Parkes GC, Din S, Hart A, Peyrin-Biroulet L, JAKne International Study Group
doi: 10.1016/j.cgh.2025.04.031
Inflammatory Bowel Disease
AGA Clinical Practice Update on Inpatient Management of Adults With Inflammatory Bowel Disease: Expert Review
Gastroenterology
Cohen-Mekelburg S, Hashash JG, Loftus EV Jr, Rubin DT
doi: 10.1053/j.gastro.2025.08.039
Inflammatory Bowel Disease
Inflammatory Bowel Disease therapies and Demyelinating Diseases: A Practical Guide to Therapeutic Benefit and Risk
J Crohns Colitis
Honap S, Debouverie M, Filippi M, Selchen D, Jairath V, Danese S, Peyrin-Biroulet L
doi: 10.1093/ecco-jcc/jjaf215
Inflammatory Bowel DiseaseFurther Publications
Bowel Urgency Improvement Correlates With Clinical, Biochemical, and Intestinal Ultrasound Improvements in Inflammatory Bowel Disease: A Cross Sectional Multicenter Study
United European Gastroenterol J
D'Amico F, Nardone OM, Bruno A, Allocca M, Zilli A, Furfaro F, Parigi TL, Solitano V, Ungaro F, Faggiani I, La Mantia A, Calabrese G, Fiorino G, Jairath V, Peyrin-Biroulet L, Massimino L, Castiglione F, Danese S
doi: 10.1002/ueg2.70129
Hepatology
Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction-associated steatotic liver diseases: Target trial emulation using real-world data
Hepatology
Ng WH, Yeo YH, Kim H, Seki E, Rees J, Ma KS, Moylan CA, Rodriquez LM, Abdelmalek M, Villanueva A, Noureddin M, Yang JD
doi: 10.1097/HEP.0000000000001333
Inflammatory Bowel Disease
Clinical Research: Disparities in Outcomes for Patients With Inflammatory Bowel Disease at a Private vs Public Hospital in New York City
Inflamm Bowel Dis
Klein S, Sivasailam B, Alizadeh M, Malter L, Axelrad JE
doi: 10.1093/ibd/izaf174
Inflammatory Bowel Disease
Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohort
Inflamm Bowel Dis
Ricciuto A, Turinsky AL, Griffiths AM, Mack DR, Wine E, Benchimol EI, El-Matary W, Huynh HQ, Carman N, deBruyn JC, Otley AR, Church PC, Jacobson K, Low S, Broer E, Lawrence S, Sherlock M, Deslandres C, Walters TD
doi: 10.1093/ibd/izaf329
RECOMMENDED
Inflammatory Bowel Disease
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Gastroenterology
Hanžel J, Solitano V, Vuyyuru SK, Panaccione R, Sands BE, Peyrin-Biroulet L, Danese S, D'Haens GR, Atreya R, Allez M, Bernstein CN, Bossuyt P, Bressler B, Bryant RV, Cohen BL, Colombel JF, D'Amico F, Dignass A, Dubinsky M, Fleshner P, Gearry RB, Hanauer SB, Hart AL, Kayal M, Kucharzik T, Lakatos PL, Louis E, Magro F, Narula N, Leong RW, Panés J, Raine T, Ran Z, Regueiro MD, Reinisch W, Singh S, Steinhart AH, Travis S, Ungaro RC, Janneke van der Woude C, Yamamoto T, Ahuja V, Rubin DT, Dulai PS, Cornfield LJ, Hogan M, Sandborn WJ, Feagan BG, Jairath V, Ma C
doi: 10.1053/j.gastro.2025.05.015
Inflammatory Bowel Disease
Tonsillectomy and the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study Using Real-World US Data
Inflamm Bowel Dis
Guo JY, Wu MC, Wang YH, Lin CC, Wei JC
doi: 10.1093/ibd/izaf306